Duke Cancer Center
Duke Cancer Center
Durham, North Carolina, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, bone marrow disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-06-15 | NCT02074839 | |
| QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations | Advanced Solid Tumors | Active, not recruiting | Phase 1 | 2026-03-02 | NCT06715124 | |
| QTX3046 in Patients With KRAS G12D Mutations | Advanced Solid Tumor | Active, not recruiting | Phase 1 | 2025-07-25 | NCT06428500 |